Introduction
Breast imaging is a key component of screening, diagnosis, treatment, and surveillance for breast cancer. Evidence-based U.S. guidelines recommend biennial mammography for average-risk women ages 50-74 years, with a preference-based approach for women ages 40-49 years [1] . Every year in the U.S., approximately 37 million screening and diagnostic mammograms are performed [2] . This translates to an estimated 70% of women aged 50-74 years undergoing screening mammography biennially, with between 9-14% receiving further diagnostic breast imaging (mammography, ultrasound, MRI) and/or biopsy [3] . The full scope of use of breast ultrasound and breast MRI is not known, but these are important breast imaging modalities for specific clinical scenarios. Ultrasound is predominantly used in the diagnostic work-up of imaging or clinical findings, and potentially screening a subset of women at increased breast cancer risk. Although there are few data supporting its use for screening based solely on higher mammographic breast density use of additional imaging technologies might be more common as breast density reporting laws are implemented. Recently passed breast density reporting laws in several states mandate that women with dense breasts be directly informed of their increased cancer risk and may benefit from supplemental screening beyond mammography [4] . Breast MRI is currently the most sensitive test for breast cancer detection, and is recommended by groups including the American Cancer Society (ACS) and the National Comprehensive Cancer Network (NCCN) annually as an adjunct to mammography for screening of women at high risk for breast cancer [5, 6] . Overall, mammography, ultrasound, and MRI or a combination of these examinations are critical in detecting, diagnosing and characterizing extent of breast cancer, and also in excluding malignancy of the breast. For each of the major clinical areas in which breast imaging is used, geographic access may determine both the availability and uptake of breast imaging services [7] [8] [9] [10] [11] , which in turn may influence treatment decisions and ultimately outcomes [12, 13] .
Prior studies have shown that longer travel time to care is associated with lower utilization of specialized services. For example, evidence suggests that travel time to breast imaging facilities may influence women's utilization of breast cancer treatment, with longer travel times associated with a greater likelihood of mastectomy instead of breast-conserving surgery [8, 10] . However, there is a lack of evidence regarding travel times required for different breast imaging modalities, despite the fact that the modalities of mammography, ultrasound and breast MRI comprise the core of recommended screening and diagnostic imaging tests. While women's ability to utilize breast services is multifactorial, proximity of services and travel time burden is one important component that warrants consideration [15] [16] [17] . Vulnerable populations have poorer access to health care resources [18] [19] [20] [21] , which may be due in part to geographic access barriers.
Our manuscript examines travel time to three types of breast imaging services--mammography, ultrasound, and MRI-for ZIP code areas of the continental U.S. We describe population characteristics in relation to travel time for each of these breast imaging modalities, and provide an overall view of geographic access to breast imaging in the U.S. for subgroups of women.
Methods

Study Population and Data
We used 2010 Census data to determine the number of women aged 30 years and older in each census block group of the contiguous U.S. [22] . The age criterion was based on ACS guidelines, which recommend screening mammograms for high-risk women starting at age 30, as well as recognizing that an estimated 12,000 women under age 40 are diagnosed with breast cancer each year [23, 24] . We excluded Alaska and Hawaii due to the lack of quality road based geospatial data. Population characteristics were based on the U.S. Census 2010 and included: age, race/ethnicity, education and median household income at the block group level. Rurality is based on the four-tier rural-urban commuting area (RUCA) designation [25, 26] . Briefly, these designations are made based on commuting patterns of the population for given areas, and include: 1. Urban Core; 2. Sub-Urban; 3. Large Rural Town; 4. Small Town/Isolated Rural [25, 26] .
Location of Breast Imaging Modalities
We took a utilization-based approach to identify breast imaging location, similar to prior studies [27] [28] [29] [30] . Specifically, using a 20% sample of Medicare Part B claims data (Carrier and Outpatient files) from 2004 -2008, we identified claims and the associated ZIP codes for mammography, breast ultrasound, and breast MRI using ICD-9 and Current Procedural Terminology (CPT) codes (Table 4) . 5,846 unique ZIP codes were identified of which 5,497 provided mammography, 5,046 breast ultrasound, and 1,783 breast MRI. We used ArcGIS v10.1 to geocode each of these breast imaging modalities to the related ZIP code centroid.
Travel Time Calculation
We obtained the TIGER/Line shapefiles [31] and calculated the centroid of each block group. Using the Network Analyst extension in ArcGIS v.10.1 and the Streetmap North America (N.A.) network dataset [32] , we calculated travel time from each block group centroid to the nearest facility offering: 1) mammography, 2) breast ultrasound, and 3) breast MRI. Continuous measures of travel time were generated for the contiguous U.S. for each modality. We categorized these times into (minutes): <=30, 31 -60, and >60 to generate a national map (Figure 1 ).
Analyses
We summarized the number of women aged 30 years and older for each travel time category and for each breast imaging modality. We then calculated the median and interquartile range of continuous travel time estimates for each modality, and the median travel times for population subgroups, including age, race/ethnicity, rurality, education, and median household income. Some research has shown that health care utilization is diminished if a service is more than 20 miles away [33] , and several state health departments have advocated for no more than 30 minutes of travel for rural patients to see a physician [34] . All analyses were performed with Stata® v.11.2.
Results
Travel time categories (minutes) for each of the 215,798 block groups in the contiguous U.S. were mapped to visually compare travel times by geographic location and by modality ( Figure 1 ). A total of 92,788,909 women aged 30 years and above were included in the population estimates for travel time. The majority of these women lived within 10 minutes of the nearest mammography and breast ultrasound services (67.2% and 65.8%), while just under half (48.7%) lived that close to breast MRI (Table 1) . Approximately 85% of the 30+ female population had 20 minutes or less travel time to nearest mammography or ultrasound. Breast MRI had the highest proportion of women living >20 minutes from the nearest location (29%) ( Table 1 ). There were no notable differences in the proportion of women in each travel time category by age ( Table 5 ).
The overall median travel time to nearest mammography or ultrasound was 6 minutes (interquartile range [IQR], 4-13 minutes); for breast MRI it was 10 minutes (IQR, 5-26) ( Table 2 ). Median travel times to the three breast imaging modalities differed markedly by population characteristics. Native American women had longer median travel times to all breast imaging modalities compared to the other racial/ethnic subgroups ( Table 2) . For breast MRI, Native Americans had median travel times that were twice as long as that of White women (median=24 min; IQR, 8-72, and 12 min; IQR 6-27, respectively), and three times longer than for other racial groups (Table 2) . Median travel times for all breast imaging modalities were shorter for Black women compared to White women (Table 2) . Travel time to MRI increased as rurality increased. For mammography and ultrasound, however, Sub-Urban areas had longer travel times than Large Rural Town areas (median for mammography: Sub-Urban, 19; IQR, 13-26, Large Rural Town, 8; IQR, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . No notable differences in median travel times by education or median household income were seen (Table 2) .
For mammography and ultrasound, only about 5% of the female population age 30+ had greater than 30 minutes travel time. For breast MRI, the proportion was almost quadruple that (19.8%) ( Table 3 ). The proportion of the Native American women age 30+ population with >30 minutes travel time to mammography and ultrasound was more than triple that for White women (39.6% v. 12.6%), and about 6 times higher than for Black women (6.4%) and Pacific Islander women (7.2%). Asian women had the lowest proportion (∼2%) of women with travel time >30 minutes to mammography and ultrasound (Table 3 ). In relation to rurality, the proportion of women with travel time >30 minutes for breast MRI was high for all but Urban Core, but for mammography and ultrasound only Small Town/Isolated Rural Areas had a notably high proportion (Table 3) . We examined the extent to which the effects of rurality and race/ethnicity were independently associated with travel time, and found that travel times for Native American women were longer regardless of rurality (Table  6 ). Differences in the proportion of women with a >30 minutes travel time to breast imaging modalities were modest in relation to educational attainment, but by income, women in the 4 th income quartile (lowest) had the lowest proportion in the >30 minutes travel time category for all imaging modalities (Table 3) .
Discussion
This study is the first to provide data regarding U.S. geographic access to the three most common breast imaging modalities. We found that the vast majority of women age 30 and older live within 30 minutes of mammography, breast ultrasound, and breast MRI. Geographic access was similar for mammography and ultrasound, but notably less for MRI. Marked differences in the proportion of women with a travel time of greater than 30 minutes to the nearest MRI were seen by race/ethnicity, rurality, and area-level median household income. A much higher proportion of Native American women had travel times of >30 minutes for all breast imaging modalities, compared to other racial/ethnic subgroups. A lower proportion of black compared to white women had >30 minutes of travel time to all three breast imaging modalities. A high proportion of rural women had >30 minutes travel time for all breast imaging, and most notably for MRI (86%). Interestingly, the lowest income quartile had the lowest proportion with >30 minutes travel time, suggesting that geographic access is not a likely barrier to utilization in this group, although transportation and other factors may be.
We found that geographic access to breast MRI is the most limited among the breast imaging modalities studied. A phenomenon that is likely to be more pronounced with even new advance technologies such as digital breast tomosynthesis. There are multiple factors that could contribute to the more limited geographic availability of MRI, including the relatively higher expense of the equipment, and lower workforce capacity with expertise in this advanced technology. Diffusion of advanced technologies often occurs unevenly, and may in fact, never reach all geographic areas due to resource allocation strategies, such as certificates of need and creation of high-volume referral centers. MRI use has increased by 3.2%-11.5% annually from 2004-2008 based on national Medicare data samples [35, 36] . This increase in advanced imaging use varies geographically by as much as 2-fold when examined at the level of the 10 national regions specified by the Centers for Medicaid and Medicare Services (CMS) [37] .
Variation in geographic access by race/ethnicity and rurality has potential implications for fully understanding mechanisms underlying disparities in health care utilization and outcomes. For example, the approximately 2.5 million women aged 30+ years who live > 30 minutes from the nearest breast imaging of any kind, may be disadvantaged for early detection of breast cancer. This is supported by previous studies have shown that rural women have a significantly greater likelihood of more advanced stage when diagnosed with breast cancer than their more urban counterparts [38] [39] [40] .
For Native American women, geographic access is relatively low for all breast imaging modalities for a large proportion of the population age 30+ years. In a 2008 Behavioral Risk Factor Surveillance System (BRFSS) report, mammography rates for Native American women were lower than for non-Hispanic white women, although the difference was not large (69% v. 76%, respectively) [41] . This could be due to Native American women finding ways to overcome barriers to travel time, or could reflect recall bias on the BRFSS survey instrument, or access to mobile vans, which we were not able to account for in this study.
Interestingly, for Black and urban women, geographic access seems less likely to be a barrier to screening compared to white and more rural women, respectively. In fact, comparable screening mammography rates have been shown for Black and White urban women [42] . However, studies examining utilization of services other than breast imaging have shown that, among urban cancer patients, Blacks were more likely than Whites to attend a NCI Cancer Center [43] . Race and rurality do seem to interact as rurality increases, with odds of attendance at an NCI Cancer Center [11] and use of screening mammography [42] dropping off significantly for increasingly rural Black individuals compared to increasingly rural Whites. The geographic component of disparities in health services utilization and patient outcomes is crucial to understand in order to identify the key causal factors underlying racial/ethnic disparities in health and health care.
Strengths of our study include calculation of travel time for all three major breast imaging modalities -mammography, ultrasound, and MRI, whereas prior studies at the national level have only included mammography, thus not capturing the full range of women's breast imaging needs and/or experiences. In addition, we characterized geographic access at the census block group level, rather than county as in prior national scale studies. However, we do note limitations in this work. First, we were only able to locate breast imaging facilities within ZIP codes, given the use of claims to identify those services so we were not able to include the actual address of the facility only the centroid of the census block. We do not measure time to mobile mammogram facilities, but do recognize that this limitation is unlikely to apply to our analysis of travel time to ultrasound or breast MRI. Also, as in most travel time studies, we used car-based travel estimates, thus did not account for other modes of transportation, such as subway, and did not explicitly incorporate public bus transportation into our estimates. Moreover, this analysis assumes that the study population has access to a vehicle. We also included only the contiguous U.S., thus are leaving out two states that have a relatively large proportion of native peoples and rural areas. Finally, the purpose of this study was to describe geographic access broadly, and did not seek to link access to utilization or outcomes. However, we recognize this as an important next step in more fully understanding utilization patterns for breast imaging, including sociodemographic disparities, potential underuse or overuse, and ultimately risk-or guideline-based care.
Geographic variability in access to breast imaging may be useful information for policy makers engaged in planning and resource allocation strategies. Understanding access may provide further insight regarding use/non-use patterns, particularly for subgroups of women and by imaging modality. For example, from this study we found a very large travel time for Native American women. Identification of regions, and the populations therein, that are subject to disadvantages in access can allow for targeted interventions, such as mobile breast imaging units, or increased availability of transportation services. Information on geographic access to breast imaging at the population level is an important first step in further understanding factors contributing to variation in breast cancer care and care outcomes. Characterizing utilization of breast imaging is an important facet of comparative effectiveness research for several reasons: 1) necessary to adjust for potential selection bias in use of imaging when comparing outcomes; 2) identification of subgroups of women for whom imaging is most effective; and 3) providing parameter inputs in decision analytic models. A first step in characterizing utilization is to determine potential access to imaging. Table 2 Median travel times to breast imaging modalities in for the U.S. population of women aged 30 years and older, by socio-demographic categories. Table 3 Population characteristics for U.S. women age 30+ with travel times of >30 minutes to the nearest breast imaging service, by modality. Table 5 Travel time to the nearest area with breast imaging services by modality for U.S. women by age categories. Median travel time in minutes to the nearest block group with breast imaging modalities for racial/ethnic populations of women age 30+ in relation to rural urban commuting area (RUCA) 4-tier categories. 
